Long‐term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open‐label phase 3 results
出版年份 2020 全文链接
标题
Long‐term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open‐label phase 3 results
作者
关键词
-
出版物
JOURNAL OF DERMATOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-10-08
DOI
10.1111/1346-8138.15605
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Questionnaire‐based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries
- (2020) Koremasa Hayama et al. JOURNAL OF DERMATOLOGY
- Clinical manifestations and quality of life in hidradenitis suppurativa patients: survey of participants from an internet support group
- (2019) Isabel Greco Tavora et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Twenty‐four‐week interim analysis from a phase 3 open‐label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa
- (2019) Akimichi Morita et al. JOURNAL OF DERMATOLOGY
- Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data
- (2019) Jessica Marvel et al. BMJ Open
- Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials
- (2019) H.H. Zee et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis
- (2018) Caitriona Ryan et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study
- (2018) Christos C. Zouboulis et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- 026 Nationwide investigation of hidradenitis suppurativa in Japan
- (2017) K. Hayama et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States
- (2017) Amit Garg et al. JAMA Dermatology
- Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
- (2016) Alexa B. Kimball et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation
- (2015) Christos C. Zouboulis et al. DERMATOLOGY
- Questionnaire surveillance of hidradenitis suppurativa in Japan
- (2015) Ichiro Kurokawa et al. JOURNAL OF DERMATOLOGY
- HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study
- (2015) A.B. Kimball et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Incidence of Hidradenitis Suppurativa and Associated Factors: A Population-Based Study of Olmsted County, Minnesota
- (2012) Benjamin G. Vazquez et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Hidradenitis Suppurativa
- (2010) F. William Danby et al. DERMATOLOGIC CLINICS
- Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
- (2009) K. Sartorius et al. BRITISH JOURNAL OF DERMATOLOGY
- Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies
- (2008) Jean E. Revuz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now